Ubrelvy, Reyvow, Rimegepant, Eptinezumab: Live Q&A With Dr. Larry Robbins

preview_player
Показать описание
Join us for a Q&A with Dr. Larry Robbins of the Robbins Headache Clinic as he answers questions about the new migraine abortive medications, Ubrelvy and Reyvow, as well as two more migraine meds expected to be FDA approved 1st quarter 2020, rimegepant and eptinezumab.

For more information, please visit the following:
Рекомендации по теме